Financial Services company CARE Ratings announced Q1FY26 results Operating Income: Rs 93.9 crore for Q1FY26, change 19% YoY. EBITDA: Rs 27.8 crore for Q1FY26, change 28% YoY. EBITDA Margin: 30% for Q1FY26. PAT: Rs 26.5 crore for Q1FY26, change 24% YoY. PAT Margin: 25% for Q1FY26. EPS: Rs 8.61 for Q1FY26. Mehul Pandya, Managing Director & Group CEO, CareEdge, said: FY26 commenced on a positive note despite the challenging global macroeconomic environment. On a standalone basis, revenue from operations for Q1FY26 registered a robust 16% year-on-year growth, while at the consolidated level, revenue grew by 19% over the same period. The profitability at standalone and consolidated levels also reflected healthy growth. This performance has been primarily driven by a healthy uptick in ratings business across the segments. Our non-ratings businesses continued their momentum of providing a good contribution in the consolidated performance. However, we continue to emphasise that our financial performance is best viewed through an annual lens. Looking ahead, we remain committed to continuously deepening our core capabilities, expanding our geographic reach, and sharpening our competitive edge - to ensure we continue to make positive impact across all the markets we serve. Result PDF
Financial Services company CARE Ratings announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Revenue from Operations: Rs 109.7 crore for Q4FY25, change 22% YoY. EBITDA: Rs 47.4 crore for Q4FY25, change 63% YoY. EBITDA margin: 43% for Q4FY25. PAT: Rs 43.4 crore for Q4FY25, change 77% YoY. PAT margin: 35% for Q4FY25. FY25 Financial Highlights: Revenue from Operations: Rs 402.3 crore for FY25, change 21% YoY. EBITDA: Rs 155.3 crore for FY25, change 39% YoY. EBITDA margin: 39% for FY25. PAT: Rs 140.0 crore for FY25, change 37% YoY. PAT margin: 31% for FY25. Mehul Pandya, Managing Director & Group CEO, Care Edge, said: “In FY25, CARE Ratings Ltd. achieved its highest-ever standalone and consolidated income from operations, registering year-on-year growth of 19% and 21%, respectively. This performance reflects our steadfast commitment to quality-led growth. Our standalone ratings business continued to demonstrate strong traction, particularly in initial ratings of capital market instruments, securitisation, and bank debt. The consolidated performance was further bolstered by an enhanced contribution from our non-ratings businesses, aided by strong showing from our overseas rating subsidiaries. The standalone EBITDA improved by 22%, underscoring our continued focus on operational efficiency. Other income also improved, supported by better yields from treasury investments. As a result, standalone PAT registered a healthy growth of 24% over the previous year. At the consolidated level, the EBITDA margin improved from 34% to 39%, reflecting significantly improved performance across our subsidiaries. Consolidated PAT margin improved from 27% to 31%, reinforcing the strength and scalability of our increasingly diversified business lines. For Q4FY25, we recorded a 22% year-on-year growth in both standalone and consolidated income from operations. Notably, standalone and consolidated PAT for the quarter grew by 29% and 77%, respectively, marking a substantial improvement in profitability across the Group. Built on strong foundations, clear vision and an unwavering commitment to quality, CareEdge is well-positioned for long-term success. I am happy to share that The Board of Directors has recommended a final dividend of Rs 11/- per share (of Rs 10/-face value) which will take the total dividend declared for the year to Rs 18/- per share." Result PDF
Financial Services company CARE Ratings announced Q3FY25 results Revenue: Rs 78.59 core, change YoY 18%. EBITDA: Rs 30.30 core, change YoY 12%. EBITDA Margins : 39% for Q3FY25. PAT: Rs 29.46 core, change YoY 33%. PAT Margins: 33% for Q3FY25. Mehul Pandya, Managing Director & Group CEO of CareEdge, said: "We are pleased to report that the company has demonstrated strong performance in both the ratings and non-ratings businesses, especially when seen against the backdrop of moderation in FY25 GDP growth projections. This performance underpins our unwavering commitment to qualityled growth. Our ratings business has continued to gain traction, particularly in the initial ratings of capital market instruments, securitisation, and bank debt. Our subsidiaries have also done well. Within the first quarter of operations, CareEdge Global Ratings assigned global scale ratings to debt issuance of ~ $2 billion across corporates and FIs. Similarly, CareEdge ESG Ratings assigned 2 ESG ratings. We aim to consistently add value for informed decision making by stakeholders through our offerings. While we are encouraged by our robust Q3FY25 performance, we re-emphasize that our financial performance should be evaluated on an annual basis rather than quarter-on-quarter or sequential quarter basis. Over the past nine months, we have seen consistently strong performance in both our ratings as well as non-ratings segments, with the contribution of non-ratings segment depicting a steady increase. We remain confident in our ability to sustain the momentum with good growth in operating revenue and profitability as evidenced by the results over the last several quarters." Result PDF